Aydın Teke Türkan, Tanır Gönül, Bayhan Gülsüm İclal, Öz Fatma Nur, Metin Özge, Özkan Şengül
Dr. Sami Ulus Maternity and Children's Training and Research Hospital, Pediatric Infectious Diseases, Turkey.
Dr. Sami Ulus Maternity and Children's Training and Research Hospital, Pediatric Infectious Diseases, Turkey.
J Infect Public Health. 2017 Mar-Apr;10(2):211-218. doi: 10.1016/j.jiph.2016.04.011. Epub 2016 May 12.
Bloodstream infections (BSIs) caused by Gram-negative (GN) bacteria cause significant morbidity and mortality. There is a worldwide increase in the reported incidence of resistant microorganisms; therefore, surveillance programs are important to define resistance patterns of GN microorganisms causing BSIs. The objective of this study was to describe the clinical and microbiological features of resistant GN BSIs in a tertiary pediatric hospital in Turkey.
Patients between 1 month and 18 years of age hospitalized between January 2005 and December 2012 were included in this study. The presence of ESBL and AmpC type beta-lactamase activity were evaluated using the Clinical and Laboratory Standards Institute (CLSI) disk diffusion and double-disk synergy tests.
A total of 209 resistant GN bacterial BSI episodes were identified in 192 patients. Of 192 children, 133 (69.2%) were aged ≤48 months of age. Sixty-six (31.6%) of the BSIs were considered community-acquired and 143 (68.4%) were hospital-acquired infections. The most common isolates were non-fermenting GN bacteria (n=117, 55.9%). The major causative pathogens were Pseudomonas spp. in non-fermenting GN bacteria. The resistance rates to imipenem for Pseudomonas spp. and Acinetobacter spp. were 40.5% and 41.6%, respectively. The most common isolates in fatal patients were Pseudomonas spp. followed by Escherichia coli. The overall 28-day mortality rate was 16.3%.
Although our study was performed at a single center and represents a local population, based on this study, it is concluded that surveillance programs and studies of novel antibiotics for resistant GN bacteria focusing on pediatric patients are required.
革兰氏阴性(GN)菌引起的血流感染(BSIs)可导致严重的发病和死亡。全球范围内,耐药微生物的报告发病率呈上升趋势;因此,监测计划对于确定引起BSIs的GN微生物的耐药模式非常重要。本研究的目的是描述土耳其一家三级儿科医院中耐药GN菌BSIs的临床和微生物学特征。
本研究纳入了2005年1月至2012年12月期间住院的1个月至18岁的患者。使用临床和实验室标准协会(CLSI)纸片扩散法和双纸片协同试验评估超广谱β-内酰胺酶(ESBL)和AmpC型β-内酰胺酶活性的存在情况。
在192例患者中总共鉴定出209例耐药GN菌引起的BSI发作。在192名儿童中,133名(69.2%)年龄≤48个月。66例(31.6%)BSIs被认为是社区获得性的,143例(68.4%)是医院获得性感染。最常见的分离株是非发酵GN菌(n = 117,55.9%)。非发酵GN菌中的主要致病菌是假单胞菌属。假单胞菌属和不动杆菌属对亚胺培南的耐药率分别为40.5%和41.6%。死亡患者中最常见的分离株是假单胞菌属,其次是大肠杆菌。28天总体死亡率为16.3%。
尽管我们的研究是在单一中心进行的,仅代表当地人群,但基于本研究得出结论,需要针对儿科患者开展耐药GN菌的监测计划和新型抗生素研究。